China and Russia have high clinical volume in paediatric stem cell therapy, though regulatory transparency is limited and outcome verification is challenging. Spain, Portugal, and Germany operate specialised neurodevelopmental centres with published protocols and higher data transparency. South Korea offers paediatric neurodevelopmental programmes with reasonable cost and documented follow-up. For families seeking regulatory accountability and published outcomes, European centres provide more reliable oversight, albeit at higher cost.
Treatments for developmental delay cost €4,500–7,500 per protocol in specialised neurodevelopmental centres. Neurogenic cell therapies command higher costs (€6,500–8,000) due to manufacturing complexity and regulatory oversight. Placental MSC infusions are moderately priced (€4,500–6,000). Most protocols involve 2–4 infusions over 6–12 months. No paediatric insurance scheme reimburses cell therapy for cognitive delay outside experimental frameworks. Families bear full out-of-pocket expense, creating significant access barriers in lower-income regions.
Am I a candidate? → · Developmental Cognitive Delay: full overview → · Developmental Cognitive Delay cost → · Cost →
Medically reviewed by StemCellAtlas’s editorial team with Kiian Nadiia, MD, PhD (Paediatric Neurologist · Medical Director, CSM Clinic Network · 12+ yrs in Autism Spectrum Disorders) of partner clinic Stem Plus (Sofia), against ISSCR, FDA & EMA guidance. Educational information, not medical advice; figures indicative.
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment